Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum is deeply committed to bringing hope and new options to patients suffering from rare hematologic diseases, and is developing a pipeline of clinical and preclinical assets. Fulcrum's lead clinical asset is Pociredir, a first-in-class small molecule designed to increase the expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies. Fulcrum's preclinical pipeline includes a novel small molecule treatment for Inherited Bone Marrow Failure Syndromes, as well as novel approaches for the potential treatment of other rare hematologic diseases. We are working to expand our portfolio of clinical-stage assets and seek a driven and strategic leader to head our Technical Operations team.
Reporting to the CSO, the Head of Technical Operations is responsible for leading and directing all chemistry, manufacturing, and controls (CMC) activities for our clinical stage products, as well as establishing our clinical and commercial supply chain infrastructure. The qualified individual will co-develop our CMC strategy with their team of direct reports, including establishing controls and supply chains suitable for a global launch. This individual will represent TechOps on cross-functional project teams, and routinely present to the Executive Team and Board of Directors.
Base Salary Pay Range
$350,000 - $380,000 USD